GlassScriptPhysician profile
Kevin J Schultz
NPI 1619110822
$4,668.61
in general payments reported to CMS, 2019-2025
18 companies · $224 in 2025
The $224 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $2,155 · 2021: $50.46 · 2022: $1,112 · 2023: $504 · 2024: $342 · 2025: $224.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,071.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,070.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,400.91 | 2020-2023 | Davinci Xi |
| Astellas Pharma US INC | $307.10 | 2023-2024 | Veozah, Myrbetriq |
| American Orthodontics Corporation | $247.93 | 2019 | |
| Hologic Sales and Service, LLC | $237.42 | 2021-2025 | Coolseal Generator, Novasure, Myosure Tissue Removal Device |
| Getinge USA Sales, LLC | $100.66 | 2024 | Cardiohelp |
| Bayer Healthcare Pharmaceuticals INC. | $78.99 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $65.46 | 2023-2025 | Gemtesa, Myfembree |
| Abbvie INC. | $40.57 | 2024-2025 | |
| Organon LLC | $30.79 | 2021-2024 | |
| Sage Therapeutics, LLC | $26.04 | 2024 | |
| Cepheid | $25.02 | 2025 | Genexpert |
| Novo Nordisk INC | $19.77 | 2025 | Ozempic |
| Therapeuticsmd, INC. | $18.13 | 2022 | |
| Amgen INC. | $17.97 | 2019 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.72 | 2024 | Caplyta |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $14.70 | 2022 | |
| Exact Sciences Corporation | $13.52 | 2024 | Cologuard Collection Kit |
| Mayne Pharma Commercial LLC | $6.91 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.